FDA Approved: OXALIPLATIN — Supplemental Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approved a supplemental application for oxaliplatin by Mylan Institutional LLC, finalizing changes to the generic product's labeling under the ANDA process.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastric Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)

Snippet

SUPPL AP for OXALIPLATIN (OXALIPLATIN)